CVS Health
$85.20Change from previous close: −0.57%Absolute change: −$0.49
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $108.97B
- Enterprise value
- $171.51B
- P/E (trailing 12 months)
- 22.5
- Forward P/E
- 9.99
- PEG
- 0.20
- Price/book
- 1.37
- Price/sales
- 0.26
- EV/EBITDA
- 10.3
- EV/revenue
- 0.42
Profitability and growth
- Gross margin
- 13.6%
- Operating margin
- 3.9%
- Net margin
- 1.2%
- ROE
- 6.2%
- ROA
- 3.0%
- Revenue growth (year over year)
- 7.1%
- Earnings growth (year over year)
- 188.8%
Financial health
- Total cash
- $13.96B
- Total debt
- $76.31B
- Debt/equity
- 0.96
- Current ratio
- 0.87
- Quick ratio
- 0.62
Dividends
- Annual dividend per share
- $2.66
- Dividend yield
- 3.1%
- Payout ratio
- 70.2%
- Ex-dividend date
- October 22, 2026
Analysts and estimates
- Average price target
- $116.28
- Median price target
- $116.00
- High price target
- $148.00
- Low price target
- $103.00
- Analysts with a price target
- 25
- Consensus
- Strong buy
- Forward EPS
- $8.53
- EPS estimate, current year
- $8.04
Shares and trading
- Beta
- 0.58
- Average volume
- 7.69M
- Shares outstanding
- 1.28B
- Float
- 1.28B
- Institutional ownership
- 90.8%
- Insider ownership
- 0.1%
- Short interest (% of float)
- 1.3%
- Short ratio (days)
- 2.77